about
The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorderAddiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulantsInfluence of methylphenidate on brain development--an update of recent animal experiments.Desperately driven and no brakes: developmental stress exposure and subsequent risk for substance abuseReducing substance use during adolescence: a translational framework for preventionSensitive periods of substance abuse: Early risk for the transition to dependenceComparing Auditory Noise Treatment with Stimulant Medication on Cognitive Task Performance in Children with Attention Deficit Hyperactivity Disorder: Results from a Pilot Study.Differences in Speech Recognition Between Children with Attention Deficits and Typically Developed Children Disappear When Exposed to 65 dB of Auditory Noise.Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.Methamphetamine and cannabis abuse in adolescence: a quasi-experimental study on specific and long-term neurocognitive effectsMethamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration.Co-segregation of hyperactivity, active coping styles, and cognitive dysfunction in mice selectively bred for low levels of anxiety.Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats.Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatmentsWhat influences clinicians' decisions about ADHD medication? Initial data from the Influences on Prescribing for ADHD Questionnaire (IPAQ).Perinatal caffeine, acting on maternal adenosine A(1) receptors, causes long-lasting behavioral changes in mouse offspring.Prenatal cocaine exposure alters alpha2 receptor expression in adolescent rats.An integrative approach to determine the best behavioral and biological markers of methylphenidate.Fluoxetine potentiates methylphenidate-induced gene regulation in addiction-related brain regions: concerns for use of cognitive enhancers?Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients.Developmental trajectories during adolescence in males and females: a cross-species understanding of underlying brain changes.Development of eye-movement controlSelective serotonin reuptake inhibitor antidepressants potentiate methylphenidate (Ritalin)-induced gene regulation in the adolescent striatum.Protracted maturation of forebrain afferent connections of the ventral tegmental area in the rat.The effects of ecstasy (MDMA) on brain serotonin transporters are dependent on age-of-first exposure in recreational users and animals.Clinically Significant Symptom Reduction in Children with Attention-Deficit/Hyperactivity Disorder Treated with Micronutrients: An Open-Label Reversal Design StudyAre adolescents more vulnerable to drug addiction than adults? Evidence from animal modelsEffects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD.Potentiated gene regulation by methylphenidate plus fluoxetine treatment: Long-term gene blunting (Zif268, Homer1a) and behavioral correlates.Early methylphenidate exposure enhances cocaine self-administration but not cocaine-induced conditioned place preference in young adult ratsMethylphenidate and atomoxetine inhibit social play behavior through prefrontal and subcortical limbic mechanisms in rats.Annual Research Review: New frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention?Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.Life-long consequences of juvenile exposure to psychotropic drugs on brain and behavior.Selective serotonin re-uptake inhibitors potentiate gene blunting induced by repeated methylphenidate treatment: Zif268 versus Homer1a.Methylphenidate treatment beyond adolescence maintains increased cocaine self-administration in the spontaneously hypertensive rat model of attention deficit/hyperactivity disorder.One-trial behavioral sensitization in preweanling rats: differential effects of cocaine, methamphetamine, methylphenidate, and D-amphetamineAdolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood.Dopamine receptor inactivation in the caudate-putamen differentially affects the behavior of preweanling and adult rats.Evidence for higher reaction time variability for children with ADHD on a range of cognitive tasks including reward and event rate manipulations.
P2860
Q22241830-A65DF2FE-86DA-4950-BE69-BCA46CFF37B3Q22251215-C999F297-C911-4F58-83E6-E6461B3F6356Q24537917-A73646DF-F15D-4696-94B2-480C53AA061BQ24653305-C139D72E-0CD4-41B3-8061-5690BF7952B7Q27023852-09D0BC2E-9985-437E-A348-1B12A201DD41Q28075281-B622DCD2-2873-4C6E-8DAD-F5329A2C69D5Q30374187-812883DF-3FA8-4DA0-8DB2-5ACB7458AF96Q30391541-6B155AB2-F337-4C47-9F19-38084F87395CQ30395001-D47EE7C0-E973-4052-B8E0-A56A3DA389FDQ30419091-1A57757A-6B40-43CE-BBC6-3DC97FFD665BQ30443801-0BC5966B-54C5-4054-8B4A-0722580E880AQ30450488-5A7BF786-F50F-42CF-AA4E-A239AC7D260CQ30547324-BC5A42B4-667E-43A5-B055-32DEC3BB69B4Q30581979-92580CBB-571F-45C3-A659-B1AFC78B5500Q30596479-2DDE196C-1758-4EBB-B7F0-83E085E3F48DQ30855196-7C6FE76C-680B-4F4D-9925-2EB4E9464BAEQ33240171-97FF1979-562B-4031-A44C-FEDB0B442507Q33283331-D7EF5B6E-5A24-4E44-B12E-84F9095577B4Q33691271-4720269D-FB03-4124-9AD4-0CDA36ADBB76Q33897101-78949EA1-ED85-4EF7-99FC-99091221A6DFQ33907518-DD1DBB3D-8269-4D4D-9EBD-4A61C943386CQ34014247-F8E7211B-2B87-48F6-9C5B-3F1EE6D3A682Q34065820-F5D4E50B-C523-4A5E-81B1-7B96C4E0AFF0Q34441382-8395B515-B92C-4ADB-A0CE-E7A3FDF00DBAQ34463526-54CAB0DC-49A5-49DA-BC91-B89A9CC5B406Q34505716-A2593B5F-5B1C-477F-B93C-86F3B22E5749Q34513218-B0357132-2ED0-48A3-80D4-FBA8096D366AQ34687232-8648D083-CA46-46B8-9FA1-B28D0ABB9924Q34707811-6AE11F0B-57F5-4CE2-8614-685554737D85Q34787716-4AD30267-D48B-4921-A82D-C546F5D81AACQ34869580-05B1936A-155D-47CA-AAFF-51F94611ABB9Q35046638-F17BE5B2-AD56-4E29-8A5D-FCE61EF9B278Q35090255-FD99455B-5889-4EBA-A78F-355896FED3B8Q35090725-322AFB55-2909-4B0F-9ECC-80AE3AB4DD5CQ35096339-C019882B-FA99-4CF9-B81E-BA68EFB892E6Q35205459-0000E0E6-D1AB-42F3-A996-9936FD22EA9DQ35243282-7CD245C5-C07E-4F03-AD7F-B672FF27433CQ36372705-46B87FC8-40BD-473B-8B49-31F70DC5C303Q36374387-FE8F10A6-A12E-432A-893D-339DACAC468FQ36466075-DBE31C2C-2686-44EE-A308-6B1A9FAB240F
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Stimulants and the developing brain.
@ast
Stimulants and the developing brain.
@en
type
label
Stimulants and the developing brain.
@ast
Stimulants and the developing brain.
@en
prefLabel
Stimulants and the developing brain.
@ast
Stimulants and the developing brain.
@en
P1476
Stimulants and the developing brain.
@en
P2093
Susan L Andersen
P304
P356
10.1016/J.TIPS.2005.03.009
P577
2005-05-01T00:00:00Z